DHNA (KIS20) is a PDH kinase 4 (PDK4) inhibitor with an IC 50 of 18 μM. DHNA can be used for the study of heart failure.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > PDHK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.